Fanfei Kong
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 8
- Cancer, Lipids, and Metabolism 2
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 5
-
- Circular RNAs in diseases 7
- RNA Research and Splicing 5
-
- Inflammatory Biomarkers in Disease Prognosis 6
-
- Cervical Cancer and HPV Research 2
Fanfei Kong
26 papers receiving 622 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 378
- Obstetrics and Gynecology 62
- Molecular Biology 422
- Oncology 151
- Reproductive Medicine 38
Countries citing papers authored by Fanfei Kong
This map shows the geographic impact of Fanfei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanfei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanfei Kong more than expected).
Fields of papers citing papers by Fanfei Kong
This network shows the impact of papers produced by Fanfei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanfei Kong. The network helps show where Fanfei Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fanfei Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 23 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 29 | |
| 7 | 2020 | 44 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 46 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 20 | |
| 12 | 2018 | 50 | |
| 13 | 2018 | 37 | |
| 14 | 2018 | 53 | |
| 15 | 2016 | 4 | |
| 16 | 2016 | 21 | |
| 17 | 2015 | 2 | |
| 18 | 2014 | 7 | |
| 19 | 2014 | 21 | |
| 20 | [Proteasome inhibitors sensitize ovarian cancer cells to paclitaxel induced apoptosis]. | 2008 | 1 |
About Fanfei Kong
Fanfei Kong is a scholar working on Cancer Research, Obstetrics and Gynecology and Oncology, having authored 26 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Endometrial and Cervical Cancer Treatments (5 papers), RNA Research and Splicing (5 papers), Cervical Cancer and HPV Research (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (378 citations), Obstetrics and Gynecology (62 citations) and Molecular Biology (422 citations). Fanfei Kong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoxin Ma, Hui Yang, Jian Ma, Rong Cong, Xiaoxin Ma, Cuicui Wang, Qi‐Jun Wu, Da Li, Di Yang and Qing Li. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Letters and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.